Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 272

Corporate venturing deal net: 20-24 January 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jan 24, 2020

Daily deal net: January 24, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jan 24, 2020

Russian Post ruminates over corporate venturing

The postal service is exploring the possibility of either putting together a dedicated investment vehicle or investing in other venture funds.

Jan 23, 2020

Tokamak racks up $87m in funding

Legal & General returned for a $87m round that will support Tokamak Energy's continual development of its compact fusion power system.

Jan 23, 2020

Daily deal net: January 22, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jan 22, 2020

Next47 buzzes along to Scoutbee’s $60m series B

Services procurement portal business Scoutbee boosted its funding haul to $76m with a round backed by Siemens's Next47.

Jan 22, 2020

HepaRegenix heaps on $12.2m

University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that featured Novo and Boehringer Ingelheim.

Jan 22, 2020

McFadgen nixes Nex Opportunities for Element Ventures

Michael McFadgen, formerly managing director at Nex Opportunities, has taken a partner position at Element Ventures, which is raising a $130m for its first fund.

Jan 21, 2020

Daily deal net: January 21, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jan 21, 2020

HepaRegenix heaps on $12.2m

University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that will fund trials of its first candidate.

Jan 21, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here